3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma, Kaposi
2
Sarcoma
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Melanoma
2
Hemangioma, Capillary
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Ulcer
1
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Smoldering Multiple Myeloma
1
Skin Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Lymphatic Metastasis
1
Liver Neoplasms
1
Fallopian Tube Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Bevacizumab
5
Cetuximab
3
palbociclib
2
encorafenib
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
tislelizumab
1
ribociclib
1
repotrectinib
1
olaparib
1
fludarabine
1
durvalumab
1
dostarlimab
1
atezolizumab
1
Tretinoin
1
Stem Cell Transplantation
1
Sirolimus
1
Ramucirumab
1
Radiotherapy
1
Paclitaxel
1
Oxaliplatin
1
Oviposition
1
Melphalan
1
Lutetium-177
1
Lutetium
1
Levoleucovorin
1
Injections
1
Immunotherapy
1
Imatinib Mesylate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Digestive System Neoplasms
×
Propranolol
×
1 year
×
Clear all
No trials found.